12324 Clinical Features And PHEX Variants Of Adults With X-Linked Hypophosphatemia Article Swipe
Luciana Pinto Valadares
,
Débora Rafaelli de Carvalho
,
Fernanda Sousa Cardoso Lopes
,
Rafael S. Oliveira
,
L G Castro
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1210/jendso/bvae163.390
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1210/jendso/bvae163.390
Disclosure: L.P. Valadares: None. D.R. Carvalho: None. F.S. Lopes: None. R.S. Oliveira: None. L.G. Castro: None. X-linked hypophosphatemia (XLH), caused by loss-of-function PHEX mutations, is a lifelong renal phosphate-wasting disorder and the main cause of inherited hypophosphatemia. In adults, chronic hypophosphatemia leads to impaired bone mineralization and persistent osteomalacia. Short stature, lower limb deformities and musculoskeletal chronic pain can significantly impact the daily lives of affected individuals. This study aimed to describe the clinical and molecular profiles of 23 adults with genetically proven XLH who are being followed at a tertiary medical center in Brazil. We conducted a retrospective analysis of their medical records. The median age at diagnosis was 3.0 years (IQR 2.0-8.0) and the mean age at first visit at the adult care unit was 30.5 years (±12.7). Their mean final height was 144.2 cm (±10.5), with a mean body mass index (BMI) of 28.1 kg/m2 (±4.9). Nine patients were overweight, and seven were obese. Sixteen patients had a positive family history of rickets, and nine had offspring with XLH. Among the 14 different PHEX mutations that were identified, six had not been previously reported. Hypophosphatemia was observed in 21 patients at presentation at the adult care unit, increased serum alkaline phosphatase levels in 19, and 12 showed increased PTH levels. Chronic bone and muscular pain were reported by sixteen patients, eighteen had lower limb deformities, and six had a history of fractures and/or pseudofractures. Seventeen patients underwent orthopedic surgeries, with an average of 3.8 surgical interventions per patient. Nephrolithiasis and/or nephrocalcinosis were observed in nine patients, but none had glomerular filtration rate below 60 mL/min adjusted to 1.73 m2 of body surface. Three patients were on conventional treatment (phosphate and calcitriol) upon presentation at the adult care unit, five patients had never received XLH-specific treatment, and fifteen discontinued conventional therapy after completing skeletal growth, with a mean therapy duration of 12.1 years (±3.5). Out of the 20 patients without treatment, 16 were initiated on pharmacological therapy based on symptoms and signs of persistent osteomalacia. Eleven started combined phosphate and calcitriol supplementation, while five received calcitriol monotherapy. This cohort underscores that adults with XLH experience significant musculoskeletal morbidity throughout their lives, and require long-term follow-up, including assessment of energy metabolism. Importantly, most of them benefits from maintaining pharmacological treatment in adulthood. Presentation: 6/2/2024
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1210/jendso/bvae163.390
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4403150451
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4403150451Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1210/jendso/bvae163.390Digital Object Identifier
- Title
-
12324 Clinical Features And PHEX Variants Of Adults With X-Linked HypophosphatemiaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-10-01Full publication date if available
- Authors
-
Luciana Pinto Valadares, Débora Rafaelli de Carvalho, Fernanda Sousa Cardoso Lopes, Rafael S. Oliveira, L G CastroList of authors in order
- Landing page
-
https://doi.org/10.1210/jendso/bvae163.390Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1210/jendso/bvae163.390Direct OA link when available
- Concepts
-
PHEX, Hypophosphatemia, Medicine, Internal medicine, Rickets, Vitamin D and neurologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4403150451 |
|---|---|
| doi | https://doi.org/10.1210/jendso/bvae163.390 |
| ids.doi | https://doi.org/10.1210/jendso/bvae163.390 |
| ids.openalex | https://openalex.org/W4403150451 |
| fwci | 0.0 |
| type | article |
| title | 12324 Clinical Features And PHEX Variants Of Adults With X-Linked Hypophosphatemia |
| biblio.issue | Supplement_1 |
| biblio.volume | 8 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11628 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9348999857902527 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2716 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Myeloproliferative Neoplasms: Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10516 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9283999800682068 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2727 |
| topics[1].subfield.display_name | Nephrology |
| topics[1].display_name | Parathyroid Disorders and Treatments |
| topics[2].id | https://openalex.org/T12876 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9139999747276306 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Potassium and Related Disorders |
| is_xpac | False |
| apc_list.value | 2822 |
| apc_list.currency | USD |
| apc_list.value_usd | 2822 |
| apc_paid.value | 2822 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2822 |
| concepts[0].id | https://openalex.org/C2776338720 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9555554389953613 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q14913440 |
| concepts[0].display_name | PHEX |
| concepts[1].id | https://openalex.org/C2778573388 |
| concepts[1].level | 2 |
| concepts[1].score | 0.862173318862915 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1641384 |
| concepts[1].display_name | Hypophosphatemia |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.3491787314414978 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.28493204712867737 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C2776489590 |
| concepts[4].level | 3 |
| concepts[4].score | 0.032963335514068604 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q183392 |
| concepts[4].display_name | Rickets |
| concepts[5].id | https://openalex.org/C124490489 |
| concepts[5].level | 2 |
| concepts[5].score | 0.0 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7936963 |
| concepts[5].display_name | Vitamin D and neurology |
| keywords[0].id | https://openalex.org/keywords/phex |
| keywords[0].score | 0.9555554389953613 |
| keywords[0].display_name | PHEX |
| keywords[1].id | https://openalex.org/keywords/hypophosphatemia |
| keywords[1].score | 0.862173318862915 |
| keywords[1].display_name | Hypophosphatemia |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.3491787314414978 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.28493204712867737 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/rickets |
| keywords[4].score | 0.032963335514068604 |
| keywords[4].display_name | Rickets |
| language | en |
| locations[0].id | doi:10.1210/jendso/bvae163.390 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735747656 |
| locations[0].source.issn | 2472-1972 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2472-1972 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of the Endocrine Society |
| locations[0].source.host_organization | https://openalex.org/P4310315851 |
| locations[0].source.host_organization_name | Endocrine Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315851 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of the Endocrine Society |
| locations[0].landing_page_url | https://doi.org/10.1210/jendso/bvae163.390 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:11455328 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | other-oa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/other-oa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | J Endocr Soc |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11455328 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5079386828 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4848-306X |
| authorships[0].author.display_name | Luciana Pinto Valadares |
| authorships[0].countries | BR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210121324 |
| authorships[0].affiliations[0].raw_affiliation_string | SARAH Network of Rehabilitation Hospitals , Brasilia , |
| authorships[0].institutions[0].id | https://openalex.org/I4210121324 |
| authorships[0].institutions[0].ror | https://ror.org/02zgfyq81 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210121324 |
| authorships[0].institutions[0].country_code | BR |
| authorships[0].institutions[0].display_name | Sarah Network of Rehabilitation Hospitals |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | L P Valadares |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | SARAH Network of Rehabilitation Hospitals , Brasilia , |
| authorships[1].author.id | https://openalex.org/A5016388382 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9812-1780 |
| authorships[1].author.display_name | Débora Rafaelli de Carvalho |
| authorships[1].countries | BR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210121324 |
| authorships[1].affiliations[0].raw_affiliation_string | SARAH Network of Rehabilitation Hospitals , Brasilia , |
| authorships[1].institutions[0].id | https://openalex.org/I4210121324 |
| authorships[1].institutions[0].ror | https://ror.org/02zgfyq81 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210121324 |
| authorships[1].institutions[0].country_code | BR |
| authorships[1].institutions[0].display_name | Sarah Network of Rehabilitation Hospitals |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | D R Carvalho |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | SARAH Network of Rehabilitation Hospitals , Brasilia , |
| authorships[2].author.id | https://openalex.org/A5102251280 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Fernanda Sousa Cardoso Lopes |
| authorships[2].countries | BR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210136843 |
| authorships[2].affiliations[0].raw_affiliation_string | Brasilia University Hospital , Brasilia , |
| authorships[2].institutions[0].id | https://openalex.org/I4210136843 |
| authorships[2].institutions[0].ror | https://ror.org/02x2gbe80 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210136843 |
| authorships[2].institutions[0].country_code | BR |
| authorships[2].institutions[0].display_name | Hospital Universitário de Brasília |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | F S Lopes |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Brasilia University Hospital , Brasilia , |
| authorships[3].author.id | https://openalex.org/A5023855087 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6392-2526 |
| authorships[3].author.display_name | Rafael S. Oliveira |
| authorships[3].countries | BR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210136843 |
| authorships[3].affiliations[0].raw_affiliation_string | Brasilia University Hospital , Braslia , |
| authorships[3].institutions[0].id | https://openalex.org/I4210136843 |
| authorships[3].institutions[0].ror | https://ror.org/02x2gbe80 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210136843 |
| authorships[3].institutions[0].country_code | BR |
| authorships[3].institutions[0].display_name | Hospital Universitário de Brasília |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | R S Oliveira |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Brasilia University Hospital , Braslia , |
| authorships[4].author.id | https://openalex.org/A5113735145 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | L G Castro |
| authorships[4].countries | BR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I150729083 |
| authorships[4].affiliations[0].raw_affiliation_string | University of Brasilia School of Medicine , Brasilia - DF , |
| authorships[4].institutions[0].id | https://openalex.org/I150729083 |
| authorships[4].institutions[0].ror | https://ror.org/02xfp8v59 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I150729083 |
| authorships[4].institutions[0].country_code | BR |
| authorships[4].institutions[0].display_name | Universidade de Brasília |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | L G Castro |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University of Brasilia School of Medicine , Brasilia - DF , |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1210/jendso/bvae163.390 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 12324 Clinical Features And PHEX Variants Of Adults With X-Linked Hypophosphatemia |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11628 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9348999857902527 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2716 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Myeloproliferative Neoplasms: Diagnosis and Treatment |
| related_works | https://openalex.org/W2073327296, https://openalex.org/W2000004275, https://openalex.org/W4205493669, https://openalex.org/W1963640137, https://openalex.org/W4396779628, https://openalex.org/W2030636938, https://openalex.org/W1984743391, https://openalex.org/W2101491452, https://openalex.org/W2045129957, https://openalex.org/W2946099268 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1210/jendso/bvae163.390 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735747656 |
| best_oa_location.source.issn | 2472-1972 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2472-1972 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of the Endocrine Society |
| best_oa_location.source.host_organization | https://openalex.org/P4310315851 |
| best_oa_location.source.host_organization_name | Endocrine Society |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315851 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of the Endocrine Society |
| best_oa_location.landing_page_url | https://doi.org/10.1210/jendso/bvae163.390 |
| primary_location.id | doi:10.1210/jendso/bvae163.390 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735747656 |
| primary_location.source.issn | 2472-1972 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2472-1972 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of the Endocrine Society |
| primary_location.source.host_organization | https://openalex.org/P4310315851 |
| primary_location.source.host_organization_name | Endocrine Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315851 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of the Endocrine Society |
| primary_location.landing_page_url | https://doi.org/10.1210/jendso/bvae163.390 |
| publication_date | 2024-10-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.a | 26, 90, 98, 140, 161, 232, 309 |
| abstract_inverted_index.12 | 209 |
| abstract_inverted_index.14 | 175 |
| abstract_inverted_index.16 | 324 |
| abstract_inverted_index.20 | 320 |
| abstract_inverted_index.21 | 192 |
| abstract_inverted_index.23 | 79 |
| abstract_inverted_index.60 | 267 |
| abstract_inverted_index.In | 38 |
| abstract_inverted_index.We | 96 |
| abstract_inverted_index.an | 244 |
| abstract_inverted_index.at | 89, 108, 119, 122, 194, 196, 287 |
| abstract_inverted_index.by | 21, 221 |
| abstract_inverted_index.cm | 137 |
| abstract_inverted_index.in | 94, 191, 206, 257, 382 |
| abstract_inverted_index.is | 25 |
| abstract_inverted_index.m2 | 272 |
| abstract_inverted_index.of | 35, 65, 78, 101, 146, 165, 234, 246, 273, 313, 318, 335, 370, 375 |
| abstract_inverted_index.on | 279, 327, 331 |
| abstract_inverted_index.to | 43, 71, 270 |
| abstract_inverted_index.19, | 207 |
| abstract_inverted_index.3.0 | 111 |
| abstract_inverted_index.3.8 | 247 |
| abstract_inverted_index.Out | 317 |
| abstract_inverted_index.PTH | 212 |
| abstract_inverted_index.The | 105 |
| abstract_inverted_index.XLH | 84, 356 |
| abstract_inverted_index.age | 107, 118 |
| abstract_inverted_index.and | 31, 47, 55, 75, 115, 154, 167, 208, 216, 229, 283, 299, 333, 342, 364 |
| abstract_inverted_index.are | 86 |
| abstract_inverted_index.but | 260 |
| abstract_inverted_index.can | 59 |
| abstract_inverted_index.had | 160, 169, 183, 225, 231, 262, 294 |
| abstract_inverted_index.not | 184 |
| abstract_inverted_index.per | 250 |
| abstract_inverted_index.six | 182, 230 |
| abstract_inverted_index.the | 32, 62, 73, 116, 123, 174, 197, 288, 319 |
| abstract_inverted_index.was | 110, 127, 135, 189 |
| abstract_inverted_index.who | 85 |
| abstract_inverted_index.(IQR | 113 |
| abstract_inverted_index.1.73 | 271 |
| abstract_inverted_index.12.1 | 314 |
| abstract_inverted_index.28.1 | 147 |
| abstract_inverted_index.30.5 | 128 |
| abstract_inverted_index.D.R. | 5 |
| abstract_inverted_index.F.S. | 8 |
| abstract_inverted_index.L.G. | 14 |
| abstract_inverted_index.L.P. | 2 |
| abstract_inverted_index.Nine | 150 |
| abstract_inverted_index.PHEX | 23, 177 |
| abstract_inverted_index.R.S. | 11 |
| abstract_inverted_index.This | 68, 350 |
| abstract_inverted_index.XLH. | 172 |
| abstract_inverted_index.been | 185 |
| abstract_inverted_index.body | 142, 274 |
| abstract_inverted_index.bone | 45, 215 |
| abstract_inverted_index.care | 125, 199, 290 |
| abstract_inverted_index.five | 292, 346 |
| abstract_inverted_index.from | 378 |
| abstract_inverted_index.limb | 53, 227 |
| abstract_inverted_index.main | 33 |
| abstract_inverted_index.mass | 143 |
| abstract_inverted_index.mean | 117, 132, 141, 310 |
| abstract_inverted_index.most | 374 |
| abstract_inverted_index.nine | 168, 258 |
| abstract_inverted_index.none | 261 |
| abstract_inverted_index.pain | 58, 218 |
| abstract_inverted_index.rate | 265 |
| abstract_inverted_index.that | 179, 353 |
| abstract_inverted_index.them | 376 |
| abstract_inverted_index.unit | 126 |
| abstract_inverted_index.upon | 285 |
| abstract_inverted_index.were | 152, 156, 180, 219, 255, 278, 325 |
| abstract_inverted_index.with | 81, 139, 171, 243, 308, 355 |
| abstract_inverted_index.(BMI) | 145 |
| abstract_inverted_index.144.2 | 136 |
| abstract_inverted_index.Among | 173 |
| abstract_inverted_index.None. | 4, 7, 10, 13, 16 |
| abstract_inverted_index.Short | 50 |
| abstract_inverted_index.Their | 131 |
| abstract_inverted_index.Three | 276 |
| abstract_inverted_index.adult | 124, 198, 289 |
| abstract_inverted_index.after | 304 |
| abstract_inverted_index.aimed | 70 |
| abstract_inverted_index.based | 330 |
| abstract_inverted_index.being | 87 |
| abstract_inverted_index.below | 266 |
| abstract_inverted_index.cause | 34 |
| abstract_inverted_index.daily | 63 |
| abstract_inverted_index.final | 133 |
| abstract_inverted_index.first | 120 |
| abstract_inverted_index.index | 144 |
| abstract_inverted_index.kg/m2 | 148 |
| abstract_inverted_index.leads | 42 |
| abstract_inverted_index.lives | 64 |
| abstract_inverted_index.lower | 52, 226 |
| abstract_inverted_index.never | 295 |
| abstract_inverted_index.renal | 28 |
| abstract_inverted_index.serum | 202 |
| abstract_inverted_index.seven | 155 |
| abstract_inverted_index.signs | 334 |
| abstract_inverted_index.study | 69 |
| abstract_inverted_index.their | 102, 362 |
| abstract_inverted_index.unit, | 200, 291 |
| abstract_inverted_index.visit | 121 |
| abstract_inverted_index.while | 345 |
| abstract_inverted_index.years | 112, 129, 315 |
| abstract_inverted_index.(XLH), | 19 |
| abstract_inverted_index.Eleven | 338 |
| abstract_inverted_index.Lopes: | 9 |
| abstract_inverted_index.adults | 80, 354 |
| abstract_inverted_index.and/or | 236, 253 |
| abstract_inverted_index.caused | 20 |
| abstract_inverted_index.center | 93 |
| abstract_inverted_index.cohort | 351 |
| abstract_inverted_index.energy | 371 |
| abstract_inverted_index.family | 163 |
| abstract_inverted_index.height | 134 |
| abstract_inverted_index.impact | 61 |
| abstract_inverted_index.levels | 205 |
| abstract_inverted_index.lives, | 363 |
| abstract_inverted_index.mL/min | 268 |
| abstract_inverted_index.median | 106 |
| abstract_inverted_index.obese. | 157 |
| abstract_inverted_index.proven | 83 |
| abstract_inverted_index.showed | 210 |
| abstract_inverted_index.Brazil. | 95 |
| abstract_inverted_index.Castro: | 15 |
| abstract_inverted_index.Chronic | 214 |
| abstract_inverted_index.Sixteen | 158 |
| abstract_inverted_index.adults, | 39 |
| abstract_inverted_index.average | 245 |
| abstract_inverted_index.chronic | 40, 57 |
| abstract_inverted_index.fifteen | 300 |
| abstract_inverted_index.growth, | 307 |
| abstract_inverted_index.history | 164, 233 |
| abstract_inverted_index.levels. | 213 |
| abstract_inverted_index.medical | 92, 103 |
| abstract_inverted_index.require | 365 |
| abstract_inverted_index.sixteen | 222 |
| abstract_inverted_index.started | 339 |
| abstract_inverted_index.therapy | 303, 311, 329 |
| abstract_inverted_index.without | 322 |
| abstract_inverted_index.(±3.5). | 316 |
| abstract_inverted_index.(±4.9). | 149 |
| abstract_inverted_index.2.0-8.0) | 114 |
| abstract_inverted_index.6/2/2024 | 385 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.X-linked | 17 |
| abstract_inverted_index.adjusted | 269 |
| abstract_inverted_index.affected | 66 |
| abstract_inverted_index.alkaline | 203 |
| abstract_inverted_index.analysis | 100 |
| abstract_inverted_index.benefits | 377 |
| abstract_inverted_index.clinical | 74 |
| abstract_inverted_index.combined | 340 |
| abstract_inverted_index.describe | 72 |
| abstract_inverted_index.disorder | 30 |
| abstract_inverted_index.duration | 312 |
| abstract_inverted_index.eighteen | 224 |
| abstract_inverted_index.followed | 88 |
| abstract_inverted_index.impaired | 44 |
| abstract_inverted_index.lifelong | 27 |
| abstract_inverted_index.muscular | 217 |
| abstract_inverted_index.observed | 190, 256 |
| abstract_inverted_index.patient. | 251 |
| abstract_inverted_index.patients | 151, 159, 193, 239, 277, 293, 321 |
| abstract_inverted_index.positive | 162 |
| abstract_inverted_index.profiles | 77 |
| abstract_inverted_index.received | 296, 347 |
| abstract_inverted_index.records. | 104 |
| abstract_inverted_index.reported | 220 |
| abstract_inverted_index.rickets, | 166 |
| abstract_inverted_index.skeletal | 306 |
| abstract_inverted_index.stature, | 51 |
| abstract_inverted_index.surface. | 275 |
| abstract_inverted_index.surgical | 248 |
| abstract_inverted_index.symptoms | 332 |
| abstract_inverted_index.tertiary | 91 |
| abstract_inverted_index.(±10.5), | 138 |
| abstract_inverted_index.(±12.7). | 130 |
| abstract_inverted_index.Carvalho: | 6 |
| abstract_inverted_index.Oliveira: | 12 |
| abstract_inverted_index.Seventeen | 238 |
| abstract_inverted_index.conducted | 97 |
| abstract_inverted_index.diagnosis | 109 |
| abstract_inverted_index.different | 176 |
| abstract_inverted_index.fractures | 235 |
| abstract_inverted_index.including | 368 |
| abstract_inverted_index.increased | 201, 211 |
| abstract_inverted_index.inherited | 36 |
| abstract_inverted_index.initiated | 326 |
| abstract_inverted_index.long-term | 366 |
| abstract_inverted_index.molecular | 76 |
| abstract_inverted_index.morbidity | 360 |
| abstract_inverted_index.mutations | 178 |
| abstract_inverted_index.offspring | 170 |
| abstract_inverted_index.patients, | 223, 259 |
| abstract_inverted_index.phosphate | 341 |
| abstract_inverted_index.reported. | 187 |
| abstract_inverted_index.treatment | 281, 381 |
| abstract_inverted_index.underwent | 240 |
| abstract_inverted_index.(phosphate | 282 |
| abstract_inverted_index.Valadares: | 3 |
| abstract_inverted_index.adulthood. | 383 |
| abstract_inverted_index.assessment | 369 |
| abstract_inverted_index.calcitriol | 343, 348 |
| abstract_inverted_index.completing | 305 |
| abstract_inverted_index.experience | 357 |
| abstract_inverted_index.filtration | 264 |
| abstract_inverted_index.follow-up, | 367 |
| abstract_inverted_index.glomerular | 263 |
| abstract_inverted_index.mutations, | 24 |
| abstract_inverted_index.orthopedic | 241 |
| abstract_inverted_index.persistent | 48, 336 |
| abstract_inverted_index.previously | 186 |
| abstract_inverted_index.surgeries, | 242 |
| abstract_inverted_index.throughout | 361 |
| abstract_inverted_index.treatment, | 298, 323 |
| abstract_inverted_index.Disclosure: | 1 |
| abstract_inverted_index.calcitriol) | 284 |
| abstract_inverted_index.deformities | 54 |
| abstract_inverted_index.genetically | 82 |
| abstract_inverted_index.identified, | 181 |
| abstract_inverted_index.maintaining | 379 |
| abstract_inverted_index.metabolism. | 372 |
| abstract_inverted_index.overweight, | 153 |
| abstract_inverted_index.phosphatase | 204 |
| abstract_inverted_index.significant | 358 |
| abstract_inverted_index.underscores | 352 |
| abstract_inverted_index.Importantly, | 373 |
| abstract_inverted_index.XLH-specific | 297 |
| abstract_inverted_index.conventional | 280, 302 |
| abstract_inverted_index.deformities, | 228 |
| abstract_inverted_index.discontinued | 301 |
| abstract_inverted_index.individuals. | 67 |
| abstract_inverted_index.monotherapy. | 349 |
| abstract_inverted_index.presentation | 195, 286 |
| abstract_inverted_index.Presentation: | 384 |
| abstract_inverted_index.interventions | 249 |
| abstract_inverted_index.osteomalacia. | 49, 337 |
| abstract_inverted_index.retrospective | 99 |
| abstract_inverted_index.significantly | 60 |
| abstract_inverted_index.mineralization | 46 |
| abstract_inverted_index.Nephrolithiasis | 252 |
| abstract_inverted_index.musculoskeletal | 56, 359 |
| abstract_inverted_index.pharmacological | 328, 380 |
| abstract_inverted_index.Hypophosphatemia | 188 |
| abstract_inverted_index.hypophosphatemia | 18, 41 |
| abstract_inverted_index.loss-of-function | 22 |
| abstract_inverted_index.nephrocalcinosis | 254 |
| abstract_inverted_index.pseudofractures. | 237 |
| abstract_inverted_index.supplementation, | 344 |
| abstract_inverted_index.hypophosphatemia. | 37 |
| abstract_inverted_index.phosphate-wasting | 29 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| citation_normalized_percentile.value | 0.32441827 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |